Becton, Dickinson and Co. (BD), a global medical technology company, is planning to invest $65 million to construct a state-of-the-art facility in Tucson that will be a hub for the company's supply chain, serving as a final-stage manufacturing and sterilization center.
The new 120,000-square-foot facility will be built on 32 acres and is planned to be operational in mid-2022. This project will become an integral part of the U.S. medical device supply chain and expands the footprint BD already has in Arizona, which includes a $1 billion business unit, headquartered in Tempe.
“Tucson is the ideal location for critical infrastructure and was selected after a careful review of a number of alternative locations in the southwestern U.S. and Mexico,” said Alexandre Conroy, executive vice president, integrated supply chain, for BD. “Arizona's favorable business climate, the strength of its workforce and Tucson's centrality to other parts of BD's supply chain were key fac
